Key Projects

Our key projects are designed to elevate the standards of patient care and best practices by the UK medical cannabis industry.

Code of Practice

The Code of Practice is a proactive demonstration that UK medical cannabis companies are compliant with the highest medical standards and prioritise patient health and wellbeing. It will ensure that clinics conduct day-to-day patient care and clinical practices – including marketing, prescribing, and arranging dispensing – in a legal and socially responsible way, providing high quality service and engagement.

In laying the foundations for a healthy, well-functioning market built on trust, cooperation and self-regulation, the code will open opportunities for dialogue with policymakers and legislators. It is also intended to establish a world standard for regulatory and scientific best practice, expanding knowledge and the evidence base, and embracing consistent standards for producers and clinics.

Data Standardisation

A pioneering real-world data collection project to establish standardised data collection procedures among clinicians prescribing Cannabis-Based Products for Medicinal Use (CBPMs). This project is led by Professor Trevor Jones and represents a groundbreaking collaboration between the United Kingdom's four premier CBPM-prescribing clinics, with academic support from Imperial College, London.

The project is actively pursuing funding from the National Institute for Health Research (NIHR) and operates in close coordination with the National Institute for Health and Care Excellence (NICE) and the Medicines and Healthcare products Regulatory Agency (MHRA). We are partnering with a leading third-party Software as a Service (SaaS) provider for data collation.

The focus of this initiative is to provide invaluable insights that will inform and influence future policies related to the use of CBPMs in the UK’s healthcare.

Condition Focus

Our conditions focused guidance for healthcare professionals provides an objective and comprehensive overview of CBPMs and their applications for a range of medical conditions.

Designed specifically for healthcare professionals, this platform aims to facilitate evidence-based decision-making and foster a deeper understanding of the potential therapeutic uses of medicinal cannabis along with its limitations.

Regulatory Review

Clarifying the definition of a CBPM is essential to developing a medical supply chain, running clinical trials and enabling NHS prescriptions. Our framework will chart the best route to reform.

Annual Patients Survey

The MCA will run an annual national patient survey designed to gauge patient satisfaction. The anonymised results will be published each November, coinciding with the anniversary of the legislation change allowing the prescribing of medical cannabis in the UK. The data may be used by the community to inform the future of patient care. It is intended that this activity will occur annually, and participation is open to any legitimate patient with a prescription from a UK-based clinic. All clinics are invited to participate and distribute the survey.